Successful Treatment of Pyoderma Gangrenosum Associated With Hidradenitis Suppurativa With Bimekizumab

A.G.O.-L. is the former President of the Pacific Dermatology Association and serves as an associate editor for Dermatology (Karger) and editorial board member of the American Journal of Clinical Dermatology. Additionally, he is a consultant for Genentec, Guidepoint, InflaRx, Corvus pharmaceuticals, Castle Biosciences, Clarivate, TFS HealthScience, Otsuka, and Leo Pharma. He is an advisor to Bristol-Meyers Squibb, Boehringer Ingelheim, Janssen, and Sanofi. Dr. Ortega has received research grants from Lilly, Janssen, Incyte, and Pfizer. He is supported by National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01 AR083110. The other authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.